These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2504222)

  • 21. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens.
    Cador M; Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1991; 104(3):377-85. PubMed ID: 1924645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apomorphine-induced facilitation of intracranial self-stimulation following dopamine denervation of the nucleus accumbens.
    Strecker RE; Roberts DC; Koob GF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1015-8. PubMed ID: 6817349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM; Stinus L; Iversen SD
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    French ED; Vantini G
    Psychopharmacology (Berl); 1984; 82(1-2):83-8. PubMed ID: 6141586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of angiotensin II on passive avoidance performance after bilateral lesion of the nucleus accumbens septi.
    Winnicka MM; Braszko J; Boguszewicz J; Wiśniewski K
    Pol J Pharmacol Pharm; 1985; 37(6):897-901. PubMed ID: 3938538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat.
    Milstein JA; Lehmann O; Theobald DE; Dalley JW; Robbins TW
    Psychopharmacology (Berl); 2007 Jan; 190(1):51-63. PubMed ID: 17096085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration.
    Dworkin SI; Guerin GF; Co C; Goeders NE; Smith JE
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1051-7. PubMed ID: 3147458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual attention in the rat: a role for the prelimbic cortex and thalamic nuclei?
    Chudasama Y; Muir JL
    Behav Neurosci; 2001 Apr; 115(2):417-28. PubMed ID: 11345966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alimentary conditioned reflex behavior in the rat following injection of 6-hydroxydopamine into the caudate nucleus and nucleus accumbens].
    Zhukova EM; Spiridonov VK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(3):490-5. PubMed ID: 3092495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration.
    Lyness WH; Friedle NM; Moore KE
    Pharmacol Biochem Behav; 1979 Nov; 11(5):553-6. PubMed ID: 531077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disinhibition of nucleus accumbens neurons by the dopamine D2 receptor agonist LY-141865: prevented by 6-OHDA pretreatment.
    Hu XT; Wang RY
    Brain Res; 1988 Mar; 444(2):389-93. PubMed ID: 2965961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine denervation of frontal cortex or nucleus accumbens does not affect ACTH-induced grooming behaviour.
    Dunn AJ; Alpert JE; Iversen SD
    Behav Brain Res; 1984 Jun; 12(3):307-15. PubMed ID: 6087843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.